$CAVC NICE FUNDING TO START WIT
RE;
CureVac in talks with pharma companies about partnership - Sueddeutsche
August 14, 2020, 12:28 pm
FRANKFURT, Aug 14 (Reuters) - German biotechnology firm CureVac is in talks with large drugmakers about a partnership to help market and distribute its prospective vaccine against the COVID-19 virus, its chief executive told Sueddeutsche Zeitung.
CureVac, backed by Microsoft founder and billionaire Bill Gates, listed on the Nasdaq stock market on Friday, raising $213 million.